TargetMol

Paliperidone

Product Code:
 
TAR-T0076
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T0076-1mL1 mL * 10 mM (in DMSO)£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0076-50mg50mg£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0076-100mg100mg£141.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0076-500mg500mg£273.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Paliperidone(Invega) is used as an atypical antipsychotic. It applies to the acute and maintenance treatment of schizophrenia. Chemically, paliperidone is the primary active metabolite of the older atypical antipsychotic risperidone.
CAS:
144598-75-4
Formula:
C23H27FN4O3
Molecular Weight:
426.492
Pathway:
GPCR/G Protein; Immunology/Inflammation; Neuroscience
Purity:
0.9698
SMILES:
Cc1nc2C(O)CCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12
Target:
Dopamine Receptor; 5-HT Receptor; Adrenergic Receptor; Histamine Receptor

References

1. Zhu HJ, et al. Neuropsychopharmacology, 2007, 32(4), 757-764. 2. Yang MC, et al. Psychopharmacology (Berl), 2011, 217(3), 397-410. 3. Gass? P, et al. Prog Neuropsychopharmacol Biol Psychiatry, 2012, 36(1), 71-77. 4. Roenker NL, et al. Neurosci Lett, 2011, 500(3), 167-171. 5. Dremencov E, et al. Psychopharmacology (Berl), 2007, 194(1), 63-72.